Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

09.10.2017

1 Adv Exp Med Biol
1 Am J Cancer Res
1 Am J Clin Pathol
2 Anticancer Res
1 Br J Cancer
1 Br J Oral Maxillofac Surg
1 Cancer Discov
1 Cell Mol Biol (Noisy-le-grand)
1 Cell Physiol Biochem
1 Chem Biodivers
1 Curr Opin Urol
1 Eur J Cancer Care (Engl)
1 Eur J Oncol Nurs
1 Eur Urol
1 Exp Ther Med
1 Genomics
1 Int J Occup Environ Med
2 J Natl Compr Canc Netw
1 J Vasc Surg
1 Jpn J Clin Oncol
2 Minerva Urol Nefrol
1 Mol Cancer Res
1 Nat Rev Urol
1 Obstet Gynecol
13 Oncotarget
1 Photochem Photobiol Sci
1 Proteomics Clin Appl
1 Radiother Oncol
1 Sci Rep
1 World J Urol



    Adv Exp Med Biol

  1. LAVDANITI M, Zyga S
    Quality of Life in Elderly Bladder Cancer Patients Following a Cystectomy.
    Adv Exp Med Biol. 2017;989:297-300.
    >> Share


    Am J Cancer Res

  2. TILLEY SK, Kim WY, Fry RC
    Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.
    Am J Cancer Res. 2017;7:1850-1862.
    >> Share


    Am J Clin Pathol

  3. FOX MD, Xiao L, Zhang M, Kamat AM, et al
    Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.
    Am J Clin Pathol. 2017;147:500-506.
    >> Share


    Anticancer Res

  4. HAQUE W, Verma V, Butler EB, Teh BS, et al
    Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics.
    Anticancer Res. 2017;37:5603-5608.
    >> Share

  5. AIZAWA R, Sakamoto M, Orito N, Kono M, et al
    The Use of External-beam Radiotherapy for Muscle-invasive Bladder Cancer in Elderly or Medically-fragile Patients.
    Anticancer Res. 2017;37:5761-5766.
    >> Share


    Br J Cancer

  6. MORERA DS, Hennig MS, Talukder A, Lokeshwar SD, et al
    Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
    Br J Cancer. 2017 Oct 3. doi: 10.1038/bjc.2017.
    >> Share


    Br J Oral Maxillofac Surg

  7. HAYAKAWA M, Kodama M, Sato S, Tomoeda-Mori K, et al
    Electrochemical telomerase assay for screening for oral cancer.
    Br J Oral Maxillofac Surg. 2016 Jan 25. pii: S0266-4356(16)00005.
    >> Share


    Cancer Discov


  8. Targeting Angiogenesis in Bladder Cancer.
    Cancer Discov. 2017 Oct 4. doi: 10.1158/2159-8290.CD-NB2017.
    >> Share


    Cell Mol Biol (Noisy-le-grand)

  9. PENCE S, Ozbek E, Ozan Tiryakioglu N, Ersoy Tunali N, et al
    rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:46-52.
    >> Share


    Cell Physiol Biochem

  10. FAN B, Zhang X, Ma Y, Zhang A, et al
    Fangchinoline Induces Apoptosis, Autophagy and Energetic Impairment in Bladder Cancer.
    Cell Physiol Biochem. 2017;43:1003-1011.
    >> Share


    Chem Biodivers

  11. RADAN M, Carev I, Tesevic V, Politeo O, et al
    Qualitative HPLC-DAD/ESI-TOF-MS Analysis, Cytotoxic, and Apoptotic Effects of Croatian Endemic Centaurea ragusina L. Aqueous Extracts.
    Chem Biodivers. 2017;14.
    >> Share


    Curr Opin Urol

  12. SORIA F, Marra G, Capoun O, Soukup V, et al
    Prevention of bladder cancer incidence and recurrence: tobacco use.
    Curr Opin Urol. 2017 Oct 3. doi: 10.1097/MOU.0000000000000453.
    >> Share


    Eur J Cancer Care (Engl)

  13. SKRZYPCZYK MA, Nyk L, Szostek P, Szemplinski S, et al
    The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection.
    Eur J Cancer Care (Engl). 2017;26.
    >> Share


    Eur J Oncol Nurs

  14. JENSEN BT, Kiesbye B, Soendergaard I, Jensen JB, et al
    Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial.
    Eur J Oncol Nurs. 2017;28:41-46.
    >> Share


    Eur Urol

  15. OHNO Y
    Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Eur Urol. 2017 Sep 26. pii: S0302-2838(17)30780.
    >> Share


    Exp Ther Med

  16. HE X, Ping J, Wen D
    MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C.
    Exp Ther Med. 2017;14:3253-3258.
    >> Share


    Genomics

  17. BAUR B, Bozdag S
    ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
    Genomics. 2017;109.
    >> Share


    Int J Occup Environ Med

  18. FARZANEH F, Mehrparvar AH, Lotfi MH
    Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study.
    Int J Occup Environ Med. 2017;8:191-198.
    >> Share


    J Natl Compr Canc Netw

  19. SPIESS PE, Agarwal N, Bangs R, Boorjian SA, et al
    Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2017;15:1240-1267.
    >> Share

  20. WARRICK JI
    Clinical Significance of Histologic Variants of Bladder Cancer.
    J Natl Compr Canc Netw. 2017;15:1268-1274.
    >> Share


    J Vasc Surg

  21. LEEMAN M, Burgers P, Brehm V, van Brussel JP, et al
    Psoas abscess after bacille Calmette-Guerin instillations causing iliac artery contained rupture.
    J Vasc Surg. 2017;66:1236-1238.
    >> Share


    Jpn J Clin Oncol

  22. TANAKA T, Koie T, Ohyama C, Hashimoto Y, et al
    Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.
    Jpn J Clin Oncol. 2017 Aug 18:1-5. doi: 10.1093.
    >> Share


    Minerva Urol Nefrol

  23. SCHIFFMANN J, Sun M, Gandaglia G, Tian Z, et al
    Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Minerva Urol Nefrol. 2017;69:173-180.
    >> Share

  24. CORONA MONTES VE, Pastore AL, Gausa L, Rodriguez-Faba O, et al
    Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indications.
    Minerva Urol Nefrol. 2017;69:153-158.
    >> Share


    Mol Cancer Res

  25. DUEX JE, Swain KE, Dancik GM, Paucek RD, et al
    Functional Impact of Chromatin Remodeling Gene Mutations and Predictive Signature for Therapeutic Response in Bladder Cancer.
    Mol Cancer Res. 2017 Oct 2. pii: molcanres.0260.2017.
    >> Share


    Nat Rev Urol

  26. THOMA C
    Bladder cancer: Drug sequencing in metastatic disease.
    Nat Rev Urol. 2017 Oct 4. doi: 10.1038/nrurol.2017.
    >> Share


    Obstet Gynecol

  27. SONG M, Glasgow M, Murugan P, Rivard C, et al
    Aggressive Angiomyxoma of the Vulva and Bladder.
    Obstet Gynecol. 2017;130:885-888.
    >> Share


    Oncotarget

  28. SONG Y, Zhang P, Sun Y, Li X, et al
    AMPK activation-dependent autophagy compromises oleanolic acid-induced cytotoxicity in human bladder cancer cells.
    Oncotarget. 2017;8:67942-67954.
    >> Share

  29. PICHLER R, Heidegger I, Fritz J, Danzl M, et al
    PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy.
    Oncotarget. 2017;8:66849-66864.
    >> Share

  30. YUAN D, Zheng S, Wang L, Li J, et al
    MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A.
    Oncotarget. 2017;8:67663-67669.
    >> Share

  31. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017;8:68115-68122.
    >> Share

  32. YANG J, Liu Y, He A, Liu Y, et al
    Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.
    Oncotarget. 2017;8:68721-68729.
    >> Share

  33. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017;8:62573-62588.
    >> Share

  34. XIE Y, Li P, Gao Y, Gu L, et al
    Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:62489-62499.
    >> Share

  35. LIU Q, Diao R, Feng G, Mu X, et al
    Risk score based on three mRNA expression predicts the survival of bladder cancer.
    Oncotarget. 2017;8:61583-61591.
    >> Share

  36. HUANG Y, Fang C, Shi JW, Wen Y, et al
    Identification of hMex-3A and its effect on human bladder cancer cell proliferation.
    Oncotarget. 2017;8:61215-61225.
    >> Share

  37. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017;8:68996-69004.
    >> Share

  38. HAMANO I, Hatakeyama S, Iwamurau H, Fujita N, et al
    Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017;8:61404-61414.
    >> Share

  39. BI H, Zhang Z, Guo L, Fu C, et al
    Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
    Oncotarget. 2017;8:63258-63264.
    >> Share

  40. MONTANO R, Khan N, Hou H, Seigne J, et al
    Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor.
    Oncotarget. 2017;8:67754-67768.
    >> Share


    Photochem Photobiol Sci

  41. GEDERAAS OA, Johnsson A, Berg K, Manandhar R, et al
    Photochemical internalization in bladder cancer - development of an orthotopic in vivo model.
    Photochem Photobiol Sci. 2017 Oct 3. doi: 10.1039/c7pp00176.
    >> Share


    Proteomics Clin Appl

  42. LATOSINSKA A, Frantzi M, Vlahou A, Merseburger AS, et al
    Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
    Proteomics Clin Appl. 2017 Oct 5. doi: 10.1002/prca.201700074.
    >> Share


    Radiother Oncol

  43. WALKER M, French SD, Doiron RC, Brennan K, et al
    Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.
    Radiother Oncol. 2017 Sep 30. pii: S0167-8140(17)32561.
    >> Share


    Sci Rep

  44. TERVAHARTIALA M, Taimen P, Mirtti T, Koskinen I, et al
    Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.
    Sci Rep. 2017;7:12682.
    >> Share


    World J Urol

  45. SORIA F, Shariat SF, Lerner SP, Fritsche HM, et al
    Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    World J Urol. 2017;35:379-387.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016